Freshpet Q3 sales beat estimates on volume gains; raises outlook
FRPT•Freshpet’s third-quarter net sales rose 10% to $317.8 million, beating the $312.04 million analyst estimate, while adjusted EPS was $0.58. The company raised its 2026 net sales growth outlook to 12%-13% and adjusted EBITDA guidance to $215 million-$220 million.
1. Quarterly results
Freshpet’s third-quarter net sales increased 10% to $317.8 million, above the $312.04 million analyst estimate. The company said the increase was primarily driven by 10% volume gains. Adjusted EPS was $0.58, and net income was $29.7 million.
2. Raised 2026 outlook
Freshpet raised its full-year 2026 net sales growth outlook to 12%-13% from 10%-12% and lifted adjusted EBITDA guidance to $215 million-$220 million from $210 million-$220 million. It expects positive free cash flow in 2026 and capital expenditures of $125 million-$150 million. Gross margin rose on improved leverage on plant expenses, reduced quality costs and lower input costs; SG&A as a percentage of sales increased mainly due to higher logistics costs and variable compensation accrual.
